REFERENCES
- Kim SY, Dabb AA, Glenn DJ, . Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatr Blood Cancer. 2008;50:779–783.
- Milligan KS, Phillips DL. Perioral numbness associated with intravenous pentamidine administration. Ann Pharmacother. 2007;41:153–156.
- Leoung GS, Feigal DW Jr, Montgomery AB, . Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med. 1990; 323:769–775.
- Lidman C, Tynell E, Berglund O, Lindback S. Aerosolized pentamidine versus i.v. pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Infection. 1993;21:146–149.
- Lin AY, Smith C. Pentamidine-induced facial numbness. Clin Pharmacol. 1991;10:257–261.